articleTop 1% cited
An analysis of 8305 cases of carcinoid tumors
Cancer · 2000 · Vol. 79(4) · pp. 813–829
Irvin M. Modlin✉(Yale University)András Sándor(Yale University)
Abstract
Carcinoids appear to have increased in incidence in the past 20 years. In part, this may be due to different surgical rules of the various registries, improved diagnostic technology, and increased awareness. A cumulative analysis of all types of carcinoid tumors in the SEER group indicates that in 45.3% metastases are already evident at the time of diagnosis. The overall 5-year survival rate of all carcinoid tumors regardless of site was 50.4% +/- 6.4%.
Neuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology ResearchIntraperitoneal and Appendiceal MalignanciesMedicineCarcinoid tumorsAppendixEpidemiologyIncidence (geometry)RectumGastroenterologyPopulationInternal medicineCancer
MeSH terms
Black or African AmericanCarcinoid TumorFemaleHumansMaleUnited StatesSurvival RateSex DistributionSEER ProgramWhite People
Citations
1,199
FWCI
45.24
field-weighted impact
References
66
Percentile
100%
vs. same field & year
Citations per year
Cited by
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
Gut · 2011 · 948 citations
A 5‐decade analysis of 13,715 carcinoid tumors
Cancer · 2003 · 2,734 citations
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
Annals of the New York Academy of Sciences · 2004 · 796 citations
References
Carcinoid TumorsAn analysis of 2837 cases
Cancer · 1975 · 1,105 citations
THE EPIDEMIOLOGY OF APPENDICITIS AND APPENDECTOMY IN THE UNITED STATES
American Journal of Epidemiology · 1990 · 2,247 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
